麥迪科技(603990.SH):終止收購蘇州美貝爾美容醫院與常熟瑞麗美貝爾醫院各不低於80%的股權
格隆匯11月5日丨麥迪科技(603990.SH)公佈,此前披露,公司第三屆董事會第二十次會議審議通過了關於與美貝爾醫療美容集團股份有限公司(“交易方”)簽署股權收購意向書的事項。公司擬收購交易方持有的蘇州美貝爾美容醫院有限公司與常熟瑞麗美貝爾醫院有限公司各不低於80%的股權。
意向書簽署後,公司聘請中介機構對標的公司進行了盡職調查,公司與交易方就收購事宜進行了多次洽談,但由於雙方未能就正式協議相關條款達成一致,經友好協商,決定終止本次股份收購,原意向書中相關約定自動解除。根據相關協議,公司與交易方均不承擔違約責任或其他責任,雙方無未了糾紛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.